ImmunityBio, Inc. (IBRX)
10.28
+1.00
(+10.83%)
USD |
NASDAQ |
Oct 02, 16:00
10.30
+0.02
(+0.15%)
After-Hours: 20:00
ImmunityBio Price : 10.28 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 9.39 | 10.55 | 9.39 | 10.28 | 31.25M |
| Oct 01, 2026 | 9.28 | 9.40 | 9.07 | 9.28 | 12.31M |
| Sep 30, 2026 | 8.92 | 10.09 | 8.90 | 9.44 | 27.29M |
| Sep 29, 2026 | 8.52 | 8.88 | 8.52 | 8.83 | 8.367M |
| Sep 28, 2026 | 8.39 | 8.979 | 8.26 | 8.52 | 10.41M |
| Sep 25, 2026 | 8.76 | 8.84 | 8.41 | 8.44 | 5.819M |
| Sep 24, 2026 | 8.50 | 8.675 | 8.31 | 8.64 | 8.980M |
| Sep 23, 2026 | 9.26 | 9.29 | 8.60 | 8.63 | 13.95M |
| Sep 22, 2026 | 8.45 | 9.48 | 8.37 | 9.29 | 21.13M |
| Sep 21, 2026 | 8.72 | 8.87 | 8.26 | 8.45 | 12.24M |
| Sep 18, 2026 | 8.46 | 8.53 | 8.20 | 8.48 | 18.43M |
| Sep 17, 2026 | 8.14 | 8.80 | 8.12 | 8.46 | 19.16M |
| Sep 16, 2026 | 8.135 | 8.30 | 7.76 | 7.91 | 9.205M |
| Sep 15, 2026 | 8.32 | 8.34 | 7.85 | 8.14 | 8.949M |
| Sep 14, 2026 | 7.89 | 8.40 | 7.87 | 8.37 | 9.158M |
| Sep 11, 2026 | 7.80 | 8.345 | 7.80 | 7.91 | 12.47M |
| Sep 10, 2026 | 7.87 | 7.89 | 7.64 | 7.72 | 8.806M |
| Sep 09, 2026 | 8.22 | 8.36 | 7.875 | 8.06 | 9.489M |
| Sep 08, 2026 | 8.00 | 8.37 | 7.93 | 8.29 | 7.741M |
| Sep 04, 2026 | 8.08 | 8.24 | 8.01 | 8.08 | 4.330M |
| Sep 03, 2026 | 8.00 | 8.21 | 7.88 | 8.19 | 5.272M |
| Sep 02, 2026 | 7.945 | 8.28 | 7.755 | 7.95 | 7.228M |
| Sep 01, 2026 | 7.82 | 7.99 | 7.73 | 7.87 | 6.466M |
| Aug 31, 2026 | 7.88 | 8.020 | 7.84 | 7.95 | 6.882M |
| Aug 28, 2026 | 8.31 | 8.320 | 7.945 | 8.05 | 7.980M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 190.01 |
| Sarepta Therapeutics, Inc. | 17.50 |
| Arrowhead Pharmaceuticals, Inc. | 64.19 |
| Oncolytics Biotech, Inc. | 0.631 |
| Sangamo Therapeutics, Inc. | 0.1475 |
Price Related Metrics
| PS Ratio | 62.24 |
| PEG Ratio | -0.1099 |
| Earnings Yield | -9.42% |
| Market Cap | 10.83B |
| PEGY Ratio | -0.1099 |